NUSAP1 and PCLAF (KIA0101) Downregulation by Neoadjuvant Therapy is Associated with Better Therapeutic Outcomes and Survival in Breast Cancer

Table 2

NUSAP1 and PCLAF and response to treatment.

	NUSAP1	PCLAF
OR	0.00	0.01
CI95%	0.000 to 0.991	0.0009 to 0.1383
p-value	0.0417	0.0001
Sensitivity	0.00	0.13
CI95%	0.000 to 0.324	0.006412 to 0.4709
Specificity	0.61	0.06452
CI95%	0.438 to 0.763	0.01146 to 0.2072
Positive predictive value	0.00	0.03
CI95%	0.000 to 0.243	0.001710 to 0.1667
Negative predictive value	0.70	0.22
CI95%	0.515 to 0.842	0.03948 to 0.5474
Likelihood ratio	0.00	0.1336